Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Moodys
Colorcon
Boehringer Ingelheim
Medtronic

Last Updated: November 28, 2022

Piperacillin sodium; tazobactam sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for piperacillin sodium; tazobactam sodium and what is the scope of freedom to operate?

Piperacillin sodium; tazobactam sodium is the generic ingredient in three branded drugs marketed by Astral, Eugia Pharma Speclts, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Provepharm Sas, Qilu, Sagent Pharms Inc, Sandoz, Sandoz Inc, Steriscience, Wockhardt Bio Ag, and Wyeth Pharms, and is included in twenty-two NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Piperacillin sodium; tazobactam sodium has forty-one patent family members in thirty-four countries.

Fifteen suppliers are listed for this compound.

Summary for piperacillin sodium; tazobactam sodium
International Patents:41
US Patents:3
Tradenames:3
Applicants:14
NDAs:22
Finished Product Suppliers / Packagers: 15
Clinical Trials: 5
DailyMed Link:piperacillin sodium; tazobactam sodium at DailyMed
Recent Clinical Trials for piperacillin sodium; tazobactam sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 2
St. Justine's HospitalPhase 1
Phillip Brian SmithPhase 1

See all piperacillin sodium; tazobactam sodium clinical trials

Pharmacology for piperacillin sodium; tazobactam sodium
Paragraph IV (Patent) Challenges for PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZOSYN For Injection piperacillin sodium; tazobactam sodium 12 g/1.5 g per vial (pharmacy bulk) 050684 1 2011-12-06

US Patents and Regulatory Information for piperacillin sodium; tazobactam sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065362-001 Oct 21, 2010 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Eugia Pharma Speclts PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065498-001 May 23, 2011 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Provepharm Sas PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 207847-001 Jan 13, 2017 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fresenius Kabi PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 203719-002 May 18, 2018 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for piperacillin sodium; tazobactam sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-002 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-003 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
Wyeth Pharms ZOSYN IN PLASTIC CONTAINER piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 050750-001 Feb 24, 1998 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for piperacillin sodium; tazobactam sodium

Country Patent Number Title Estimated Expiration
Israel 171337 PHARMACEUTICAL COMPOSITIONS CONTAINING PIPERACILLIN AND TAZOBACTAM, USES THEREOF AND PROCESSES FOR THE PREPARATION THEREOF See Plans and Pricing
Canada 2464258 COMPOSITIONS RENFERMANT DE LA PIPERACILLINE ET DU TAZOBACTAMUTILES EN INJECTION (COMPOSITIONS CONTAINING PIPERACILLIN AND TAZOBACTAM USEFUL FOR INJECTION) See Plans and Pricing
Costa Rica 8035 COMPOSICIONES QUE CONTIENEN PIPERACILINA Y TAZOBACTAM UTILES PARA INYECCIONES See Plans and Pricing
Russian Federation 2007142454 КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПИПЕРАЦИЛЛИН И ТАЗОБАКТАМ, ПРИМЕНИМЫЕ ДЛЯ ИНЪЕКЦИИ See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Merck
McKesson
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.